Evidence map›Paper›PMID 41592082›Full record

ArticlePloS one2026

Breast cancer histopathological image classification based on collaborative multi-domain feature learning.

Lingfei He, Hongping Hu, Rong Cheng

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lingfei HeSchool of Mathematics, North University of China, Taiyuan, Shanxi, China.
Hongping HuSchool of Mathematics, North University of China, Taiyuan, Shanxi, China.ORCID https://orcid.org/0000-0001-9708-9141
Rong ChengSchool of Mathematics, North University of China, Taiyuan, Shanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a highly heterogeneous malignant tumor, and its accurate classification is of great significance for clinical diagnosis and treatment decision-making. In recent years, convolutional neural networks and Transformer have been widely used in pathological image analysis of breast cancer. Though the former excels at capturing local information and the latter is adept at modeling global dependencies, the former is limited by fixed sampling positions and is hindered to characterize irregular cell morphology, the latter is insufficient in describing the two-dimensional spatial structure of cells and tissues. Based on these, a Spatial-Frequency Domain Feature Extraction Model (S-FDFEM) proposed in this paper integrates spatial and frequency domain information to enhance feature learning for pathological image recognition. Specifically, in the spatial domain, Deformable Bottleneck Convolution (DBottConv) is utilized to effectively represent intricate cell and tissue morphological variations in pathological images and improve the expression ability of local features; in the frequency domain, wavelet low frequencies and Fourier high frequencies are generated based on the input pathological images to capture global approximation and fine structures, then statistical transformer and depth gradient feature extraction modules are integrated to operate on these two frequency domain components, enabling global dynamic focusing and two dimensions spatial characterization of pathological images. Experimental results show that the classification of breast cancer pathological image on BreakHis and BACH datasets verify the superiority of the S-FDFEM proposed in this paper.

Indexed as

Breast NeoplasmsImage Processing, Computer-AssistedAlgorithmsClassification AlgorithmsConvolutional Neural NetworksFemaleHumans

Identifiers

PMID41592082
PMCPMC12843584

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.